SPARC to raise Rs 250 crore through rights issue

Image
Press Trust of India New Delhi
Last Updated : May 12 2015 | 8:32 PM IST
Drug discovery firm Sun Pharma Advanced Research Company (SPARC) plans to raise up to Rs 250 crore through a rights issue.
"The Board of Directors of the Company at its meeting held on May 12, 2015, authorised the further issuance of equity shares of Re 1 each of the company, on rights basis to the shareholders of the company...The funds raised by way of right issue of shares is not more than Rs 250 crore," SPARC said in a filing to the BSE.
It further said that the issue price and record date for fixing the entitlement of shareholders for the right issue would be informed in due course.
Sun Pharma Advanced Research Company was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
Shares of SPARC closed at Rs 379.50 per scrip on the BSE, down 4.05 per cent from the previous close.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 12 2015 | 8:32 PM IST

Next Story